University of California San Francisco
Give to UCSF
A drug commonly used during invasive heart procedures not only helps maintain blood flow through the large blood vessels that have been enlarged during the procedure, but also preserves blood flow through the smaller blood vessels downstream that may become blocked by debris.
In findings that could lead to a new Alzheimer's disease drug, researchers at SFVAMC and University of California, San Francisco have isolated a protein fragment that nurtures brain cells, an effect that could prevent loss of brain function caused by the disease.
A study undertaken for the Food and Drug Administration to assess the safety of popular dietary supplements containing ephedra concludes that these products can pose severe health risks and even kill some people...
Researchers led by University of California, San Francisco and Harvard School of Public Health are reporting the largest randomized trial among HIV-1 infected persons conducted during the 1990s.
While private industry involvement in academic research continues to grow rapidly, universities struggle to prevent potential conflicts of interest without clear guidelines for defining or managing financial conflicts...
A popular herbal supplement used by prostate cancer patients has been found to significantly reduce prostate specific antigen (PSA) levels -- a protein in the blood that often indicates prostate cancer...
HIV prevention resources are not allocated in the most cost-effective fashion say researchers at the UCSF Center for AIDS Prevention Studies (CAPS).
UCSF-led scientists have determined that under certain conditions the Ras oncogene, a key culprit in many cancers, suppresses the function of the p53 tumor-suppressor gene...
A University of California, San Francisco biochemist and colleagues have revealed the atom-by-atom structure of an ancient and extremely discriminating kind of channel embedded in cell membranes, from bacteria to humans.
A recent study of San Francisco Bay Area physicians reports on successful intervention techniques for victims of domestic violence.
A team of scientists at the University of California, San Francisco and Compugen, Ltd. has discovered a new molecule of the immune system -- a member of a family of proteins called chemokines which recruit the body's army of defensive immune cells to sites of invasion.
University of California San Francisco researchers may have discovered why the experimental anti-cancer drug Onyx-015 works more broadly than had been expected...
Cardiopulmonary (CPR) training can relieve stress for parents and improve survival outcomes for infants at high risk for cardiopulmonary arrest, a new study has found.
A team led by a University of California, San Francisco scientist has developed drug-like inhibitors to study vital signaling molecules essential for almost all cell activity.
Jeffrey A. Bluestone, PhD, one of the world's leading experts on why the body's immune system rejects or tolerates transplanted tissue, has been appointed to a new professorship at the University of California, San Francisco devoted to diabetes research.
A new $50 million dollar research program launched this month will begin the daunting task of mapping out the thousands of molecular interactions that cells use in responding to their environment.
The new optimism expressed by healthcare providers treating HIV seropositive patients is mitigated by concerns surrounding treatment decisions and skepticism about the future according to a new University of California, San Francisco study.
While California's labor market continues to be strong, Latinos and African Americans - who together make up 31 percent of California's working population - are being left behind by the state's technology-driven economic boom...
Results of the 2000 California Work and Health Survey (CWHS) indicate high employment rates among all working age Californians, long hours of work and large numbers of workers who report promotions, new and better jobs and increased earnings.